CMS Concerned About Low COVID-19 Booster Rates In Nursing Homes

CMS says nursing homes can pre-order COVID-19 treatments in case of an outbreak in guidance released Tuesday (Nov. 22), while also expressing concerns that only 44% of residents have received the updated COVID-19 booster shot -- and in some places, no residents have received a booster.

Tags: 
Site Name: 
InsideHealthPolicy.com
Email Subject Line: 
Nursing Homes Pressed On Boosters
CMS Issue: 
Inside CMS - 12/01/2022
CMS Volume: 
Vol. 25, No. 48
Author: 

Admin: More Than 3M Enroll In ACA Plans In First Few Weeks

The Biden administration Tuesday (Nov. 22) announced that about 3.4 million people have selected Affordable Care Act coverage through one of the state-based exchanges or healthcare.gov since the No. 1 start of open enrollment.

Tags: 
Site Name: 
InsideHealthPolicy.com
CMS Issue: 
Inside CMS - 12/01/2022
CMS Volume: 
Vol. 25, No. 48
HEA Issue: 
Health Exchange Alert Weekly Report - 11/30/2022
HEA Volume: 
Vol. 10, No. 48
Author: 

WH Urges COVID Booster Uptake As CDC Data Reinforce Protection

New data reveal that receiving the Omicron booster offers significantly more protection against symptomatic coronavirus infections than receiving just two doses of the original vaccine, the Centers for Disease Control and Prevention announced Tuesday (Nov. 22), coming as the White House pushes a “six-week sprint” to get Americans vaccinated before the end of the year.

Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 11/25/2022
FDA Volume: 
Vol. 28, No. 47
CMS Issue: 
Inside CMS - 12/01/2022
CMS Volume: 
Vol. 25, No. 48
HEA Issue: 
Health Exchange Alert Weekly Report - 11/30/2022
HEA Volume: 
Vol. 10, No. 48
Author: 












Pazdur, Califf Seek To Simplify Trials, Ensure They Represent U.S. Patients

FDA chief Robert Califf and Oncology Center of Excellence head Richard Pazdur are worried about clinical trials being moved outside of the United States, and the agency is looking to do something about it, including by simplifying the clinical trial process.

Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 11/25/2022
FDA Volume: 
Vol. 28, No. 47
Author: 

Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.